BackBiofrontera AG Overview

Biofrontera AG Current Cash

Track Biofrontera AG's current cash ($30M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$29.54M
↑ 77.74% YoYΔ $12.92M vs prior year quarter

Peer average

Loading

Biofrontera AG Current Cash History

Loading

Biofrontera AG vs. peers: Current Cash Comparison

Loading

Biofrontera AG Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Biofrontera AG (BFRA) FAQ

Biofrontera AG (BFRA) currently reports a current cash of $30M as of September 2021. That compares with $17M in the prior-year period — up 77.7% year over year. Use the charts on this page to explore Biofrontera AG's current cash history and peer comparisons.

Biofrontera AG's current cash increased from $17M to $30M — a 77.7% year-over-year increase (period ending September 2021). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Biofrontera AG reported $30M in current cash as of September 2021. That compares with $17M in the prior-year period — up 77.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current cash of $30M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Biofrontera AG, and consider following BFRA for alerts when major investors trade the stock.

Biofrontera AG is classified in the Healthcare sector. On current cash, it currently shows $30M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BFRA with unrelated industries.